Cargando…

Pediatric Cancer Immunotherapy: Opportunities and Challenges

Cancer immunotherapies, widely heralded as transformational for many adult cancer patients, are becoming viable options for selected subsets of pediatric cancer patients. Many therapies are currently being investigated, from immunomodulatory agents to adoptive cell therapy, bispecific T-cell engager...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wedekind, Mary Frances, Denton, Nicholas L., Chen, Chun-Yu, Cripe, Timothy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153971/ https://www.ncbi.nlm.nih.gov/pubmed/29948928 http://dx.doi.org/10.1007/s40272-018-0297-x

Ejemplares similares

Oncolytic virus and PD-1/PD-L1 blockade combination therapy
por: Chen, Chun-Yu, et al.
Publicado: (2018)

Opportunities and challenges of combining adoptive cellular therapy with oncolytic virotherapy
por: Mamola, Joseph A., et al.
Publicado: (2023)

Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
por: Denton, Nicholas L., et al.
Publicado: (2016)

Immunotherapies for Pediatric Solid Tumors: A Targeted Update
por: Gupta, Ajay, et al.
Publicado: (2021)

Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)

Ovarian cancer immunotherapy: opportunities, progresses and challenges
por: Liu, Bei, et al.
Publicado: (2010)

Immunotherapies for pediatric cancer: current landscape and future perspectives
por: Hutzen, Brian, et al.
Publicado: (2019)

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
por: Young, Kate, et al.
Publicado: (2018)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Challenges and Opportunities for Effective Cancer Immunotherapies
por: Slaney, Clare Y., et al.
Publicado: (2020)

T cell immunotherapy for cervical cancer: challenges and opportunities
por: Yu, Lingfeng, et al.
Publicado: (2023)

Immunotherapeutic Challenges for Pediatric Cancers
por: Hutzen, Brian, et al.
Publicado: (2019)

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
por: Maravelia, Panagiota, et al.
Publicado: (2021)

Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities
por: Curley, Colleen T., et al.
Publicado: (2017)

Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children
por: Cripe, Timothy P, et al.
Publicado: (2015)

Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children
por: Friedman, Gregory K, et al.
Publicado: (2015)

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities
por: Pardee, Angela D., et al.
Publicado: (2012)

CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities
por: Ren, Anqi, et al.
Publicado: (2023)

Pediatric dental sedation: challenges and opportunities
por: Nelson, Travis M, et al.
Publicado: (2015)

Pediatric Interventional Neuroradiology: Opportunities and Challenges
por: Jerele, Cene, et al.
Publicado: (2023)

The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?
por: Paudel, Siddhi N., et al.
Publicado: (2023)

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
por: Noman, Muhammad Zaeem, et al.
Publicado: (2019)

Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
por: Shi, Guilian, et al.
Publicado: (2019)

Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review
por: Xia, Wu-Yan, et al.
Publicado: (2020)

Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges
por: Pappas, Evan G., et al.
Publicado: (2023)

Golden Age of Immunotherapy: Challenges and Opportunities
por: Chung, Yeonseok, et al.
Publicado: (2022)

New opportunities for nanoparticles in cancer immunotherapy
por: Park, Wooram, et al.
Publicado: (2018)

Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities
por: Kwee, Sandi, et al.
Publicado: (2022)

Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy
por: Sachamitr, Patty, et al.
Publicado: (2014)

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy
por: Ocáriz-Díez, Maitane, et al.
Publicado: (2020)

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016)

Immunotherapies targeting tumor vasculature: challenges and opportunities
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2023)

Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
por: Verheye, Emma, et al.
Publicado: (2022)

Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy
por: Agrawal, Shruti, et al.
Publicado: (2016)

Radio-pathomic approaches in pediatric neuro-oncology: Opportunities and challenges
por: Familiar, Ariana M, et al.
Publicado: (2023)

Surface-Enhanced Raman Spectroscopy for Cancer Immunotherapy Applications: Opportunities, Challenges, and Current Progress in Nanomaterial Strategies
por: Dey, Shuvashis, et al.
Publicado: (2020)

Therapeutic modulation of the CD47-SIRPα axis in the pediatric tumor microenvironment: working up an appetite
por: Gupta, Ajay, et al.
Publicado: (2020)

Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016)

Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges
por: Qiu, Bo, et al.
Publicado: (2021)

Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy
por: Agrawal, Shruti, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ebetp2oq4m296rj8m9c95qap98